Glioma microenvironment emerges as key target for future therapies
The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and…
Thymulin curbs age-related inflammation and slows breast tumors in mice
A thymus-derived peptide reduced inflammatory immune activity and improved immunotherapy responses in aged mice, suggesting a potential strategy…
New smart drugs precisely target and kill cancer cells
Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting…
Study explores racial differences in gastric cancer immunotherapy outcomes
Advanced gastric cancer remains one of the deadliest malignancies, with a 5-year overall survival rate below 10%. In…
Scientists discover why some cancer treatments stop working
A quiet problem has followed cancer immunotherapy for years. The immune system can be taught to fight, then…
Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and…
Lactylation drives tumor progression and immune evasion in triple negative breast cancer
Breast cancer maintains its position as the most prevalent malignancy in women worldwide, with triple-negative breast cancer (TNBC)…